0 avis
Exploring the expanded role of pharmacists in advance care planning
Article indépendant
Purpose: Advance care planning (ACP) is a clinical skill that can be taught. An opportunity exists to teach how to conduct ACP to clinicians not typically engaged in these conversations to increase the likelihood that patients and caregivers engage in ACP. We conducted a prospective study exploring the feasibility of a pharmacist-led ACP intervention.
Methods: We completed a prospective, single-center study from July 2015 to July 2017. We included patients of age = 18 years with incurable cancer referred to the palliative care clinic. A trained pharmacist led an ACP discussion with the patient and selected proxy. We defined feasibility as completion of = 30 pharmacist-led ACP discussions over the study period. Additionally, we defined an informed healthcare proxy as someone who understood three key end-of-life (EOL) treatment preferences: the patient's personal definition of quality of life, desired resuscitation status, and preferred location of death (in or out of the hospital). Patients were followed until the end of the study or death. For those patients who died, the pharmacist contacted the proxy for follow-up and explored satisfaction with the ACP intervention.
Results: Thirty-four patients completed the study. All selected proxies completed the intervention and were able to understand the three EOL preferences. At the time of the patient’s death (n = 20), proxies reported that 66.6% received their preferred resuscitation status and 72.2% died in their preferred location. Proxy satisfaction with the ACP process was 7.6 ± 2.5 (mean ± SD) on a 11-point Likert scale.
Conclusion: These findings indicate the potential for pharmacists to lead and engage in ACP in the outpatient setting.
http://dx.doi.org/10.1200/OP.20.00684
Voir la revue «JCO oncology practice»
Autres numéros de la revue «JCO oncology practice»
Consulter en ligne
Suggestions
Du même auteur
De la même série